glucose Cancer Research Results
glucose, glucose: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
*antiOx↑, *hepatoP↑, *RenoP↑, AntiTum↑, *glucose↝, *Inflam↓, *neuroP↑, *ROS↓, *Keap1↓, *NRF2↑, *SOD↑, *Catalase↑, *GPx↑, *GSH↑, *MDA↓, *p‑ERK↑, *GRP78/BiP↑, *CHOP/DDIT3↑, *GRP94↑, *Casp3↓, *Casp9↓, *HGF/c-Met↑, *TNF-α↓, *TLR4↓, *MAPK↓, *IL1β↓, *iNOS↓, TCA↓, Glycolysis↓, Bcl-2↓, BAX↑, MAPK↑, JNK↑, CSCs↓, Nanog↓, SOX2↓, CD44↓, OCT4↓, P53↑, P21↑, *SOD1↑, *AGEs↓, *GLUT2↑, *HDL↑, *Fas↓, *HMG-CoA↓, *NF-kB↓, *HO-1↓, *COX2/PTGS2↓, *TLR4↓, *BioAv↑, *BioAv↝, TumCP↓, TumCMig↓, TumCI↓,
*neuroP↑, *BioAv↑, *GutMicro↑, *BBB↑, *Aβ↓, *glucose↝,
*Dose↝, *ROS↓, *compI↑, *compIII↑, *ATP↑, *Ca+2↓, *Iron↓, *Casp3↓, *glucose↝, *ACE/ACE1↑, *AChE↓,
*Inflam↓, *ROS↓, *BioAv↓, *GutMicro↑, *neuroP↑, *glucose↝, *AntiThr↑, *chemoP↑, *Half-Life↝, *BBB∅, *AntiAge↑, Risk↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Diabetic, |
NA |
|
|
|
*IRes↓, *AntiDiabetic↑, *glucose↝, AntiCan↑, PI3K↓, Akt↓, Glycolysis↓, STK11/LKB1↑, *FASN↓, *LDL↓, *FFA/NEFA↓, *ROS↓, ROS↑, IGF-1↓,
*glucose↝, *lipid-P↓, *ROS↓, *BioAv↑, *hepatoP↑, *Inflam↓, *MMP↑, *ATP↑, *GutMicro↑, *Dose↝, *Half-Life↝, *BioAv↑, *Synergy↑, *hepatoP↑, *SOD↑, *Catalase↑, *Casp3↓, *ALAT↓, *AST↓, *AMPK↑, *SREBP1/SREBF1↑, NA↑,
*other↝, *Inflam↓, *Bacteria↓, *antiOx↑, *AntiP↑, *neuroP↑, *glucose↝, *lipid-P↓, PKCδ↓, P70S6K↓, Akt↓, ER Stress↑, Apoptosis↑, Ca+2↑, PI3K↓, mTOR↓, Casp3↑, Bcl-2↓, Cyt‑c↑, BAX↑, cl‑PARP↑, cycD1/CCND1↑, ROS↑, CHOP/DDIT3↑, ERK↑, p38↑, JNK↓, IAP1↓, XIAP↓, survivin↓, cFLIP↓, RIP1↓, EGFR↓, MET↓, HER2/EBBR2↓, p‑4E-BP1↓, PERK↑, eIF2α↑, PD-L1↓, HK2↓, Glycolysis↓, Sp1/3/4↓, FasL↑, MMP↓, ATP↓, TumAuto↑, WEE1↑, P21↑, CDK1↓, TumCCA↑, TumCMig↓, TumCI↓, ABCG2↓, HSP90↓, T-Cell↑, CD4+↑, CD25+↑, FOXP3↑, Imm↝, *Inflam↓, *NF-kB↓, *NRF2↑, *AntiArt↑, *antiAll↑, *MUC5AC↓, *E-sel↓, *CCL11↓,
*lipidLev↓, *cardioP↑, *glucose↝, *Weight↓, *cognitive↑, *GutMicro↑,
Showing Research Papers: 1 to 8 of 8
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 8
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
NA↑, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
ROS↑, 2,
Core Metabolism/Glycolysis(tgid=4) ⓘ
ATP↓, 1, Glycolysis↓, 3, HK2↓, 1, TCA↓, 1,
Cell Death(tgid=5) ⓘ
Apoptosis↑, 1, BAX↑, 2, Bcl-2↓, 2, Casp3↑, 1, cFLIP↓, 1, Cyt‑c↑, 1, FasL↑, 1, IAP1↓, 1, p38↑, 1, survivin↓, 1, XIAP↓, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
Akt↓, 2, EGFR↓, 1, ERK↑, 1, HER2/EBBR2↓, 1, JNK↓, 1, JNK↑, 1, MAPK↑, 1, mTOR↓, 1, P70S6K↓, 1, PI3K↓, 2, PKCδ↓, 1, RIP1↓, 1, Sp1/3/4↓, 1, STK11/LKB1↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
OCT4↓, 1, SOX2↓, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
CHOP/DDIT3↑, 1, eIF2α↑, 1, ER Stress↑, 1, HSP90↓, 1, PERK↑, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
TumAuto↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
P53↑, 1, cl‑PARP↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK1↓, 1, cycD1/CCND1↑, 1, P21↑, 2, TumCCA↑, 1, WEE1↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
p‑4E-BP1↓, 1, CSCs↓, 1, IGF-1↓, 1, Nanog↓, 1, TumCP↓, 1,
Migration(tgid=13) ⓘ
Ca+2↑, 1, MET↓, 1, TumCI↓, 2, TumCMig↓, 2,
Barriers & Transport(tgid=15) ⓘ
MMP↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
CD25+↑, 1, CD4+↑, 1, CD44↓, 1, FOXP3↑, 1, Imm↝, 1, PD-L1↓, 1, T-Cell↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
ABCG2↓, 1,
Clinical Biomarkers(tgid=22) ⓘ
EGFR↓, 1, HER2/EBBR2↓, 1, PD-L1↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1, AntiTum↑, 1, Risk↑, 1,
Total Targets: 70
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 2, Catalase↑, 2, GPx↑, 1, GSH↑, 1, HDL↑, 1, HO-1↓, 1, Iron↓, 1, Keap1↓, 1, lipid-P↓, 2, MDA↓, 1, NRF2↑, 2, ROS↓, 5, SOD↑, 2, SOD1↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
compI↑, 1, compIII↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
ALAT↓, 1, AMPK↑, 1, ATP↑, 2, FASN↓, 1, FFA/NEFA↓, 1, glucose↝, 8, HMG-CoA↓, 1, LDL↓, 1, lipidLev↓, 1, SREBP1/SREBF1↑, 1,
Cell Death(tgid=5) ⓘ
Casp3↓, 3, Casp9↓, 1, Fas↓, 1, iNOS↓, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
p‑ERK↑, 1, HGF/c-Met↑, 1, MAPK↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
AntiThr↑, 1, other↝, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
CHOP/DDIT3↑, 1, GRP78/BiP↑, 1, GRP94↑, 1,
Migration(tgid=13) ⓘ
Ca+2↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
E-sel↓, 1,
Barriers & Transport(tgid=15) ⓘ
BBB↑, 1, BBB∅, 1, GLUT2↑, 1, MMP↑, 1, MUC5AC↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
CCL11↓, 1, COX2/PTGS2↓, 1, IL1β↓, 1, Inflam↓, 5, NF-kB↓, 2, TLR4↓, 2, TNF-α↓, 1,
Synaptic & Neurotransmission(tgid=18) ⓘ
AChE↓, 1,
Protein Aggregation(tgid=19) ⓘ
AGEs↓, 1, Aβ↓, 1,
Hormonal & Nuclear Receptors(tgid=20) ⓘ
ACE/ACE1↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 1, BioAv↑, 4, BioAv↝, 1, Dose↝, 2, Half-Life↝, 2, Synergy↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
ALAT↓, 1, AST↓, 1, IRes↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiAge↑, 1, antiAll↑, 1, AntiArt↑, 1, AntiDiabetic↑, 1, cardioP↑, 1, chemoP↑, 1, cognitive↑, 1, hepatoP↑, 3, neuroP↑, 4, RenoP↑, 1, Weight↓, 1,
Infection & Microbiome(tgid=24) ⓘ
AntiP↑, 1, Bacteria↓, 1, GutMicro↑, 4,
Total Targets: 79
Scientific Paper Hit Count for: glucose, glucose
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:1 prod#:% Target#:1278 State#:% Dir#:4
wNotes=0 sortOrder:rid,rpid
Home Page